Hope for Patients: Hormone Therapy Reduces Recurrence Risk in Breast Cancer
Breast cancer is one of the most common types of cancer in women, with millions of people being diagnosed every year. While modern medicine has advanced significantly in recent years, offering various treatment options, many patients still face the risk of recurrence. However, recent research shows that hormone therapy has the potential to significantly reduce the risk of breast cancer recurrence, providing hope for patients.
Hormone therapy is a type of treatment that works by blocking the production of hormones that stimulate the growth of breast cancer cells. This treatment is often used in combination with chemotherapy, radiation therapy, and surgery. The therapy is most often used for patients who have estrogen receptor-positive breast cancer, which means that the cancer cells have receptors that bind to the hormone estrogen.
Recent studies have found that hormone therapy can reduce the risk of recurrence in many women. The benefits of hormone therapy depend on the patient’s age, menopausal status, and whether the patient has invasive or non-invasive cancer. However, it has been found that women who receive hormone therapy have a 50% lower risk of recurrence compared to those who do not receive hormone therapy.
In addition, hormone therapy can also extend the survival rates of patients who were at high risk of recurrence. Studies show that the five-year survival rate of patients who receive hormone therapy for estrogen-positive breast cancer is 85% compared to 79% who do not receive hormone therapy.
Hormone therapy comes in several forms, including pills, injections, and frequent infusions. Pill medication is generally the most common form, and it is usually taken once per day. For postmenopausal women, the most common medication used is aromatase inhibitors. Additionally, for women who are still experiencing their menstrual cycles, Tamoxifen is the first-line medication.
Hormone therapy also has several side effects, including weight gain, hot flashes, and mood changes. Still, these side effects are similar to those experienced during natural menopause, which most women experience, making it a viable option for many patients.
In conclusion, hormone therapy is an effective option for reducing the risk of breast cancer recurrence in women. While the treatment has side effects, the benefits can significantly improve a patient’s prognosis and provide hope for a long-term favorable outcome. It is recommended that patients discuss their eligibility for hormone therapy with a medical professional to determine if it’s the right course of treatment for them.